About the MSSO

The MSSO is made up of medical officers and support staff. The medical officers are involved in maintaining the terminology, and working on various projects including legacy data conversion, training, consulting, and MedDRA needs assessments. They are also an integral part of ongoing terminology development efforts, such as Standardised MedDRA Queries, Product quality, Medical Device, and pharmacogenetic/pharmacogenomic related terms.

The MedDRA Management Board, appointed by the ICH Steering Committee, has overall responsibility for direction of MedDRA, an ICH standardized dictionary. The Board oversees the activities of the MedDRA MSSO. The Management Board is composed of the six ICH Parties (EU, EFPIA, MHLW, JPMA, FDA, PhRMA), the Medicines and Healthcare products Regulatory Agency (MHRA) of the UK, the Health Canada and the WHO (as Observer). The IFPMA acts as a non-voting observer on the Management Board and chairs the Board.

The MedDRA MSSO staff ensures that daily operational processes and medical reviews of the MedDRA terminology are performed utilizing the highest quality standards in the industry. The MSSO team possesses a wide range of background experiences in the Biopharmaceutical, Regulatory, and IT industries. We are an internationally focused team with members who were educated in Canada, China, Germany, India, Spain, the United Kingdom, and the United States. The MSSO also has a partnership with the Japanese Maintenance Organization.

Key Members of the MSSO